|
EstraceDrug - Estrace The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Estradiol
Strength -
0.5MG
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
081295
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Jun 30, 1993
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Bristol Myers Squibb Co
Estrace
Vivelle-dot 0.025mg/24hr Film, Extended Release; Transdermal
Vivelle-dot 0.0375mg/24hr Film, Extended Release; Transdermal Vivelle-dot 0.05mg/24hr Film, Extended Release; Transdermal Vivelle-dot 0.075mg/24hr Film, Extended Release; Transdermal Vivelle-dot 0.1mg/24hr Film, Extended Release; Transdermal Estrogel 0.06% Gel, Metered; Topical Estrogel 0.06% Gel; Topical Estring 0.0075mg/24hr Insert, Extended Release; Vaginal Estrace 0.5mg Tablet; Oral Vivelle 0.1mg/24hr Film, Extended Release; Transdermal NewDrugInformation |